For Changing Healthcare

Asia’s Leading Healthcare Private Equity Firm

Transforming healthcare in Asia

Philosophy

We invest in large growth, scalable healthcare companies in Asia with clear market differentiation, strong management teams, and potential to emerge as market leaders.

Learn More →

Process

As a strategic investor, we take an industrial approach to partnership. We unlock value by leveraging our deep domain expertise, operational experience, and industry network.

Learn More →

People

We have one of the largest dedicated healthcare investment and operational excellence teams in Asia, with deep expertise and technical know-how.

Learn More →

Performance

By enabling our portfolio companies to scale and strengthen their capabilities, we support exceptional growth, deliver top financial returns and create meaningful social impact.

Learn More →

AT A GLANCE

US$
0

Billion Assets Under Management

0

Investments Across 7 Markets

US$
0

Billion Capital Returned To Investors

0
+

Million Lives Touched

INVESTMENT HIGHLIGHTS

Partnered For
  • Growth
  • Success
  • Excellence

NephroPlus

NephroPlus is Asia’s largest dialysis network with over 435 centers operating across 4 countries, serving patients on dialysis to lead long, happy and productive lives.

Date of investment: 2024
Country: India
Markets Served: India, Philippines, Uzbekistan and Nepal
Sector: Healthcare Delivery

Learn More →

Maxivision

As one of India’s fastest-growing eye care chains with a leading position in core regions of South and West India, Maxivision serves a vast population of 450 million and is dedicated to providing quality and affordable eye care services.

Date of investment: 2023
Country: India
Markets Served: India
Sector: Healthcare Delivery

Learn More →

Straits Orthopaedics

As the premier manufacturer of orthopedic implants, surgical tools, and instruments, Straits Orthopaedics offers comprehensive end-to-end manufacturing capabilities with advanced technology and equipment that meet the most stringent regulatory and compliance standards.

Date of investment: 2023
Country: Malaysia
Markets Served: Worldwide
Sector: MedTech CDMO

Learn More →